<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lee CS</submitter><funding>NICHD NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>807-20</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4838559</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(4)</volume><pubmed_abstract>Few apoptotic corpses are seen even in tissues with high cellular turnover, leading to the notion that the capacity for engulfment in vivo is vast. Whether corpse clearance can be enhanced in vivo for potential benefit is not known. In a colonic inflammation model, we noted that the expression of the phagocytic receptor Bai1 was progressively downmodulated. Consistent with this, BAI1-deficient mice had more pronounced colitis and lower survival, with many uncleared apoptotic corpses and inflammatory cytokines within the colonic epithelium. When we engineered and tested transgenic mice overexpressing BAI1, these had fewer apoptotic cells, reduced inflammation, and attenuated disease. Boosting BAI1-mediated uptake by intestinal epithelial cells (rather than myeloid cells) was important in at</pubmed_abstract><journal>Immunity</journal><pubmed_title>Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo.</pubmed_title><pmcid>PMC4838559</pmcid><funding_grant_id>R01 GM107848</funding_grant_id><funding_grant_id>HD074981</funding_grant_id><funding_grant_id>GM064709</funding_grant_id><funding_grant_id>T32 AI007496</funding_grant_id><funding_grant_id>R01 GM064709</funding_grant_id><funding_grant_id>F30 HL126385</funding_grant_id><funding_grant_id>R01 HD074981</funding_grant_id><funding_grant_id>T32-AI1007496</funding_grant_id><funding_grant_id>MH096484</funding_grant_id><funding_grant_id>R01 MH096484</funding_grant_id><pubmed_authors>Lysiak JJ</pubmed_authors><pubmed_authors>Ravichandran KS</pubmed_authors><pubmed_authors>Wheeler KM</pubmed_authors><pubmed_authors>Vandenabeele P</pubmed_authors><pubmed_authors>Lee CS</pubmed_authors><pubmed_authors>Juncadella IJ</pubmed_authors><pubmed_authors>Penberthy KK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo.</name><description>Few apoptotic corpses are seen even in tissues with high cellular turnover, leading to the notion that the capacity for engulfment in vivo is vast. Whether corpse clearance can be enhanced in vivo for potential benefit is not known. In a colonic inflammation model, we noted that the expression of the phagocytic receptor Bai1 was progressively downmodulated. Consistent with this, BAI1-deficient mice had more pronounced colitis and lower survival, with many uncleared apoptotic corpses and inflammatory cytokines within the colonic epithelium. When we engineered and tested transgenic mice overexpressing BAI1, these had fewer apoptotic cells, reduced inflammation, and attenuated disease. Boosting BAI1-mediated uptake by intestinal epithelial cells (rather than myeloid cells) was important in at</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2026-05-05T08:29:50.367Z</modification><creation>2019-03-27T02:12:04Z</creation></dates><accession>S-EPMC4838559</accession><cross_references><pubmed>27037190</pubmed><doi>10.1016/j.immuni.2016.02.005</doi></cross_references></HashMap>